Related Experiment Video
Updated: Jan 18, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
The diagnostic status of chronic kidney disease in a real-world database in Japan: CHECK-CKD
Toshiki Moriyama1, Keigo Kanafuri2, Mayu Kanno2
1Health and Counseling Center, Osaka University, 1-17, Machikaneyama-cho, Toyonaka-shi, Osaka, 560-0043, Japan. toshiki.moriyama@gmail.com.
Insights
Chronic kidney disease (CKD) diagnosis rates in Japan remained low despite guidelines. Early detection through periodic blood and urine tests is crucial for managing CKD and preventing complications.
Area of Science:
- Nephrology
- Public Health
- Epidemiology
Background:
- CKD management in Japan was expected to improve following 2018 guidelines and 2021 therapeutic agent launch.
- The actual status of CKD diagnosis rates and management remains unclear.
- This study investigates CKD diagnosis trends and outcomes in Japan.
Purpose of the Study:
- To evaluate changes in CKD diagnosis rates from 2014 to 2023.
- To identify factors associated with CKD diagnosis.
- To assess the prognostic impact of CKD diagnosis timing on cardiorenal events.
Main Methods:
- Retrospective observational study using administrative claims and medical checkup data (2014-2023).
- Inclusion criteria: patients with potential CKD risk (eGFR < 60 mL/min/1.73 m² and/or urine protein ≥1+).
- Analysis of CKD diagnosis rates, patient characteristics, and cardiorenal event incidence.
Main Results:
- Approximately 3% of patients newly met CKD diagnostic criteria annually until 2021.
- CKD diagnosis was associated with blood/urine tests, anemia, heart failure, and diabetes.
- Incidence of cardiorenal events at 36 months was 4.5% for stage 3a and 12.4% for stage 3b CKD.
Conclusions:
- The prevalence of CKD diagnosis in Japan is low, with infrequent renal function testing.
- Early detection of CKD through regular blood and urine tests is recommended.
- Timely diagnosis and management are critical for improving patient outcomes and reducing cardiorenal events.
Background:
The clinical practice guidelines for chronic kidney disease (CKD) in 2018 and the launch of the first therapeutic agent in 2021 are expected to have improved CKD management in Japan. However, the reality of CKD diagnosis in this environment is poorly understood. Here, we conducted a retrospective observational study.
Methods:
We investigated the changes in CKD diagnosis rates, the characteristics of diagnosed cases, and the prognostic impact of the timing of diagnosis by using a database of administrative claims and medical checkups from 2014 to 2023 (DeSC Healthcare Inc.™) for patients with a potential risk of CKD (eGFR <60 mL/min/1.73 m2 and/or urine protein qualitative test result of ≥1+).
Results:
We extracted 287,999 patients who newly met the diagnostic criteria for CKD at a medical checkup. The rate of new CKD diagnosis remained ~ 3% until 2021. Factors associated with CKD diagnosis included blood/urine tests at a medical institution (odds ratio [OR] 4.11, 95% confidence interval [CI] 3.92-4.31; OR 5.02, 95% CI 4.82-5.22) and presence of comorbidities: anemia (OR 2.30; 95% CI 2.16-2.45), heart failure (OR 1.87; 95% CI 1.76-1.98), and diabetes (OR 1.84; 95% CI 1.76-1.91). The incidence of cardiorenal-related events at 36 months after the date when patients newly met the CKD diagnostic criteria was 4.5% and 12.4% for those diagnosed at stage 3a and 3b, respectively.
Conclusions:
The prevalence of CKD diagnosis was low and renal function tests were infrequently performed. Periodic blood/urine tests may help clinicians to detect CKD in an early phase.
Study Registration:
UMIN000052393.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

